BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7872774)

  • 1. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV; Reyes VE; Humphreys RE
    Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the invariant chain C-terminus (Glu183-Glu193) epitope which is obscured in processed Ii, MHC alpha,beta trimers.
    Nguyen QV; Knapp W; Humphreys RE
    Mol Immunol; 1993 Dec; 30(18):1679-84. PubMed ID: 7505883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC; Sairenji T; Humphreys RE
    J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant chain influences post-translational processing of HLA-DR molecules.
    Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
    J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA; Cresswell P
    J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
    J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats.
    Reske K; Weitzel R
    Eur J Immunol; 1985 Dec; 15(12):1229-39. PubMed ID: 3878790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.
    Reyes VE; Lu S; Humphreys RE
    J Immunol; 1991 Jun; 146(11):3877-80. PubMed ID: 2033257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic cleavage of Ii to p25.
    Thomas LJ; Nguyen QV; Elliott WL; Humphreys RE
    J Immunol; 1988 Apr; 140(8):2670-4. PubMed ID: 3282009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments.
    Humbert M; Raposo G; Cosson P; Reggio H; Davoust J; Salamero J
    Eur J Immunol; 1993 Dec; 23(12):3158-66. PubMed ID: 8258330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).
    Quaranta V; Majdic O; Stingl G; Liszka K; Honigsmann H; Knapp W
    J Immunol; 1984 Apr; 132(4):1900-5. PubMed ID: 6199417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
    Simonis S; Miller J; Cullen SE
    J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
    Hess AD; Thoburn CJ; Chen W; Bright AE
    Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, biosynthesis, and polymorphism of chicken MHC class II (B-L) antigens and associated molecules.
    Guillemot F; Turmel P; Charron D; Le Douarin N; Auffray C
    J Immunol; 1986 Aug; 137(4):1251-7. PubMed ID: 2942601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
    Powis SJ
    FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.